142 filings
Page 4 of 8
8-K
8gaydsoc
28 Sep 21
Other Events
4:05pm
8-K
99wi6vwl
9 Sep 21
Regulation FD Disclosure
6:13am
8-K
5tm16 nz6
24 Aug 21
Other Events
9:07am
8-K
71fytqeu0wrb06
5 Aug 21
Akebia Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Milestones
8:06am
8-K
fpcf1
3 Jun 21
Submission of Matters to a Vote of Security Holders
8:01am
8-K
7yqo1raeungo
1 Jun 21
Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat
6:08am
8-K
p01 4j3pk6
10 May 21
Akebia Reports First Quarter 2021 Financial Results and Highlights Recent Company Milestones
8:11am
8-K
fzk2c fz1k4p
30 Mar 21
Akebia Submits New Drug Application (NDA) to the FDA for Vadadustat for the Treatment of
9:07am
8-K
xuoc5db94
25 Feb 21
Akebia Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides
8:04am
8-K
c19jllvhotd zl7g
18 Feb 21
Departure of Directors or Certain Officers
8:03am
8-K
zlrn pc4bqm1w
17 Feb 21
Entry into a Material Definitive Agreement
4:06pm
8-K
94lvvuq4j3k40 mux
28 Jan 21
Departure of Directors or Certain Officers
4:29pm
8-K
nfad la4tenoqtfma3
12 Jan 21
Regulation FD Disclosure
7:06am
8-K
4ye6u8via0x82kbw3cx7
15 Dec 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8:22am
8-K
skptllstrba0
2 Dec 20
Entry into a Material Definitive Agreement
4:17pm
8-K
2syk7
5 Nov 20
Akebia Reports Third Quarter 2020 Financial Results and Recent Business Updates
8:15am
8-K
nj0u keyk25bpqighc
25 Sep 20
Other Events
8:16am
8-K
o9hjgo qdfzpfmhts88s
11 Sep 20
Entry into a Material Definitive Agreement
5:00pm
8-K
1pj9vpoch1gmo2ngdwu
3 Sep 20
Akebia Therapeutics Announces Top-Line Results from its PRO2TECT Global Phase 3 Program of
4:55pm
8-K
t2a0cl0759iu
10 Aug 20
Akebia Reports Second Quarter 2020 Financial Results
4:02pm